医药生物行业：MNC管线数据预期差带来的潜在BD机会－代谢类

医疗保健行业：GLP－1RAs引领降糖减重市场，更多适应症有待开发－GLP－1受体激动剂行业深度报告

中药行业在医药板块中具备类似银行行业的属性，现金充裕分红高，利润增长波动少，海外局势影响小。 2025Q2行业营收和归母净利润增速环比2025Q1均有改善，在中药材降价带来的成本压力减轻下，我们预计2025H2行业业 绩增速有望环比2025H1好转。

中国创新医药企业机遇与挑战

美容护理行业：细分化功效化趋势不改，国货洗护潜力无限－洗护行业深度研究报告

The market by value in this report is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography.

The market by value in this report is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography. • Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market by value in this report is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography. • Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The global hemostats and tissue sealants market was sized near USD 6931.42 million in 2023 in terms of value. Hemostatic agents and tissue sealants are frequently employed in reconstruction during surgical repair, to stop excessive blood loss. Thrombin sealant, fibrin glue, bovine serum/albumin/glutaraldehyde, and gelatin matrix are some major products offered in the market. Each of these agents has a unique mechanism, price, and use. There are different types of diseases that are treated by different surgeries, but surgery has long been concerned about blood loss. There have long been techniques to stop bleeding and mend wounds. Numerous hemostatic medications and tissue sealants have been created during the past 20 years and are being utilized in a variety of surgical specialties. Hemostatic agents are designed to halt bleeding either through mechanical means or by enhancing the natural coagulation cascade. On the other hand, tissue sealants are products that adhere to and seal defects in tissue, promoting hemostasis and facilitating the healing process. The hemostatic agents function by physically blocking or promoting clot formation, while tissue sealants work by creating a barrier that supports tissue repair and regeneration. The selection of the appropriate agent depends on the specific clinical situation and the patient's individual needs. Healthcare professionals must carefully consider the characteristics of each product and their potential benefits and risks when deciding on the most appropriate treatment option.

The market by value in this report is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography. • Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.